🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

An Ultrasound Guided Automated Spinal Landmark Identification System

RecruitingNAAges 21 Years - 75 YearsFemaleKK Women's and Children's Hospital
NCT03687411 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Neuraxial ultrasonography has been shown a safe and effective technique to enhance the overall success rate of lumbar puncture and reduce the number of injection attempts. However, the current blind palpation landmark technique is known to be highly inaccurate and may increase the risk of multiple insertion attempts, patient suffering and complication rates such as spinal cord injury. Various clinical studies have confirmed the effectiveness of ultrasound imaging compared with the traditional palpation method. However, none of the present system can achieve real-time guidance. The overall aim of this proposal is to develop an ultrasound guided automated spinal landmark identification with real-time neuraxial needle insertion system (uSINE) to improve patient safety and efficacy of neuraxial procedure needle insertion success. This will be achieved in 4 phases of technology development a

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: First phase: * Age 21 - 75 years old patients who require neuraxial anesthesia for surgical procedure; * Normal body mass index (Weight 40-90 kg, Height 140-180cm). Second-fourth phases: * Obese patients aged between 21-75 years old; * body mass index more than 30. Exclusion Criteria: * History of scoliosis; * History of spinal instrumentation; * Drug allergy to ultrasound transmission gel; * Visible wound or injury in the lumbar spine.
💊

What it tests

  • Neuraxial ultrasonography
📍

Where

1 site
KK Women's and Children's Hospital
Singapore, Singapore
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy